Trial Profile
Comparison of the efficacy and tolerability of moxiflocaxin, gatifloxacin, and cefazolin + tobramycin in patients with bacterially-infected corneal ulcers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2011
Price :
$35
*
At a glance
- Drugs Gatifloxacin (Primary) ; Moxifloxacin (Primary) ; Cefazolin; Tobramycin
- Indications Bacterial infections; Corneal ulcer
- Focus Therapeutic Use
- 14 Feb 2011 New trial record